Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Breast Cancer 2022

Start date: 03 May 2022
End date: 05 May 2022
Location: Berlin, Germany

ESMO Breast Cancer 2022 took place as a hybrid meeting, onsite in Berlin, Germany, on 3-5 May 2022, and online, through a virtual platform.

ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care.

The 2022 edition focused on:

Integrating translational research insights from HER2 positive and HER2 low disease, antibody drug conjugates, immune modulation into cancer care
Further improving precision medicine
Building the knowledge base for breast cancer prevention, diagnosis and treatment, encompassing PRO and real-world data
Highlighting breakthroughs in management of patients with triple negative breast cancer
Informing on state-of-the-art peri operative therapy for localised breast cancer

Programme

The ESMO Breast Cancer 2022 programme is online!

Abstracts

The abstract submission system is now closed

Information for Presenters

Find here instructions to assist with your presentation

Congress Officers

Industry Participation

Industry Sponsored Satellite Symposia

ESMO Breast Cancer 2022

ESMO Colloquia

The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community.